Dnmt3b Antibody, anti-human/mouse/rat, REAfinity™
Synonyms: ICF, MmuIIIB, ICF1, M.HsaIIIB
RECOMBINANT
Clone:
REA565 | 52A1018
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for Dnmt3b Antibody, anti-human/mouse/rat, REAfinity™

Intracellular flow cytometry applications
APC
PE
Description:
Human HepG2 cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-Dnmt3b antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.
Intracellular flow cytometry applications
APC
PE
pure
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-132-433, 130-132-469
Description:
Human HepG2 cells were fixed and permeabilized using the Cell Signaling Buffer Set A. Cells were then stained with Anti-Dnmt3b antibodies or with the corresponding REA Control (I) antibodies (left peak) and analyzed using the MACSQuant® Analyzer. Cell debris were excluded from the analysis based on scatter signals.

Application image
MICS (MACSima Imaging Cyclic Staining) applications
APC
PE
Fixation:
FFPE
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-132-433, 130-132-469
Testing grade:
Specifications for Dnmt3b Antibody, anti-human/mouse/rat, REAfinity™
Overview

Clone REA565 recognizes the Dnmt3b antigen, which is a DNA methyltransferase, that performs de novo DNA methylation during embryonic development. It may function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation and may play a role in controlling the differentiation of human ES cells and in the generation of iPS cells. Dnmt3 is expressed ubiquitously, at higher levels expressed in mouse and human embryonic stem (ES), in fetal liver, heart, kidney, and placenta.

Additional information: Clone RE565 displays negligible binding to Fc receptors.

Alternative names

ICF, MmuIIIB, ICF1, M.HsaIIIB

Detailed product information

Technical specifications

Clone
REA565
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human, mouse, rat
Antigen
Dnmt3b
Molecular mass of antigen [kDa]
96, 97, separately shown for human and mouse/rat
Entrez Gene ID
RRID
AB_2928620, AB_2651580, AB_2905185, AB_2905184, AB_2928619

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for Dnmt3b Antibody, anti-human/mouse/rat, REAfinity™
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Dnmt3b Antibody, anti-human/mouse/rat, REAfinity™
Publications
  1. Yajun, L. et al. (2010) Interaction between DNMT3B and polycomb repression complexes and their role in histone modification. Cancer Res. 70: 4868-4868
  2. Torroglosa, A. et al. (2014) Involvement of DNMT3B in the pathogenesis of Hirschsprung disease and its possible role as a regulator of neurogenesis in the human enteric nervous system. Genet. Med. 16 (9): 703-710
  3. Niederwieser, C. et al. (2015) Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia. Leukemia 29 (3): 567-575
  4. Wongtrakoongate, P. et al. (2014) DNMT3B inhibits the re-expression of genes associated with induced pluripotency. Exp. Cell Res. 321 (2): 231-239

You have previously chosen International as your location.
What do you want to do?